Patent · US Active

Heterocyclic compounds

US8143282B2 · kind B2 · utility

6Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 1, 2006
Grant dateMar 27, 2012
Priority date
Expiry dateMay 1, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds which are inhibitors of histone deacetylase. More particularly, the present invention relates to heterocyclic compounds and methods for their preparation. These compounds may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with enzymes having histone deacetylase (HDAC) activities.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.